Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06613568 · ClinicalTrials.gov registry record · NA
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
A NA study of End-Stage Kidney Disease, sponsored by Diality.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 4
- Study locations
NCT06613568: Recruiting NA study of End-Stage Kidney Disease, sponsored by Diality.
NCT06613568 is a NA study of End-Stage Kidney Disease that is actively recruiting participants, run by Diality. The registered enrollment target is 50 participants, below the 463-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06613568, a NA study of End-Stage Kidney Disease, is actively recruiting participants, sponsored by Diality.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners
Primary Outcome
Standardized weekly (stdKt/V) values as measured once every week during the Professional Care and At Home treatment settings
Conditions Studied
Interventions
- DEVICE Moda-flx Hemodialysis System™
Study Locations (4)
California
- North America Research Institute - San Dimas
Tennessee
- Nephrology Associates of Knoxville - Knoxville
Texas
- aQua Research Institute, LLC - Houston
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-06 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT06613568 shows while recruiting
NCT06613568 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 463-participant average among 20 other End-Stage Kidney Disease trials with a reported enrollment target (89% lower).
The record links to 1 condition, with End-Stage Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Moda-flx Hemodialysis System™ is the first listed.
NCT06613568 reports a single indexed study location in California, Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT06613568 about?
NCT06613568 is a clinical study titled "Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants". The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners
What is the current status of trial NCT06613568?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-06. Estimated completion is 2027-09.
What conditions does trial NCT06613568 study?
This clinical trial studies the following conditions: End-Stage Kidney Disease.
What interventions are being tested in trial NCT06613568?
The interventions under investigation include: Moda-flx Hemodialysis System™ (DEVICE).
Who is sponsoring clinical trial NCT06613568?
This trial is sponsored by Diality, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06613568 being conducted?
This trial has 4 study locations across California, Tennessee, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End-Stage Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06613568's enrollment target sits among peer trials
50 14th of 20 higher than 7 of 20 other End-Stage Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End-Stage Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Incremental Hemodialysis: The TwoPlus Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Symptom Monitoring in Hemodialysis
RECRUITING · NA
-
Pain Reduction Using NEurostimulation Study
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
-
The Arteriovenous Vascular (AV) ACCESS Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI